SANDOZ' CPMS PATIENT MANAGEMENT SYSTEM MUST BE DELETED FROM CLOZARIL LABEL, FDA SAYS; LABEL SHOULD CITE MONITORING NEED, NOT COMMERCIAL VENTURE

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".